| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.273 | 19.478 | 12.992 | 20.215 | 34.233 | 29.671 | 31.188 |
| Total Income - EUR | - | - | - | 1.273 | 19.478 | 12.992 | 20.215 | 34.234 | 29.671 | 31.188 |
| Total Expenses - EUR | - | - | - | 0 | 5.711 | 6.223 | 9.204 | 15.221 | 18.983 | 27.423 |
| Gross Profit/Loss - EUR | - | - | - | 1.273 | 13.767 | 6.769 | 11.012 | 19.014 | 10.688 | 3.765 |
| Net Profit/Loss - EUR | - | - | - | 1.235 | 13.183 | 6.650 | 10.809 | 18.671 | 10.392 | 2.829 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Diabetclin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 1.316 | 15.635 | 4.217 | 9.340 | 4.146 | 14.372 | 16.199 |
| Inventories | - | - | - | 0 | 49 | 233 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.273 | 8.755 | 794 | 2.690 | 0 | 299 | 3.884 |
| Cash | - | - | - | 43 | 6.831 | 3.190 | 6.651 | 4.146 | 14.073 | 12.315 |
| Shareholders Funds | - | - | - | 1.235 | 14.435 | 7.879 | 10.850 | 18.712 | 12.280 | 15.041 |
| Social Capital | - | - | - | 0 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 81 | 1.200 | 1.780 | 1.523 | 906 | 2.092 | 1.158 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabetclin S.r.l.